financetom
Business
financetom
/
Business
/
Garmin's Fiscal Q3 Adjusted Earnings Flat, Revenue Rises; Fiscal 2025 Adjusted EPS Guidance Raised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Garmin's Fiscal Q3 Adjusted Earnings Flat, Revenue Rises; Fiscal 2025 Adjusted EPS Guidance Raised
Oct 29, 2025 5:02 AM

07:31 AM EDT, 10/29/2025 (MT Newswires) -- Garmin ( GRMN ) reported fiscal Q3 adjusted earnings Wednesday of $1.99 per diluted share, unchanged from a year earlier.

Analysts polled by FactSet expected $1.99.

Net sales for the fiscal quarter ended Sept. 27 were $1.77 billion, up from $1.59 billion a year earlier.

Analysts polled by FactSet expected $1.78 billion.

The company said it now expects fiscal 2025 adjusted EPS to be $8.15, up from $8 previously. Analysts polled by FactSet expect $8.16.

The company continues to expect revenue for the fiscal year of about $7.10 billion. Analysts polled by FactSet expect $7.17 billion.

Shares of Garmin ( GRMN ) were down more than 6% in recent premarket activity Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alkami Technology Insider Sold Shares Worth $51,950,010, According to a Recent SEC Filing
Alkami Technology Insider Sold Shares Worth $51,950,010, According to a Recent SEC Filing
Aug 12, 2024
05:38 PM EDT, 08/12/2024 (MT Newswires) -- Brian R Smith, 10% Owner, Director, on August 08, 2024, sold 1,666,667 shares in Alkami Technology ( ALKT ) for $51,950,010. Following the Form 4 filing with the SEC, Smith has control over a total of 17,734,039 shares of the company, with 784,549 shares held directly and 16,949,490 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1529274/000094787124000675/xslF345X03/ownership.xml...
Cytokinetics Insider Sold Shares Worth $276,000, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $276,000, According to a Recent SEC Filing
Aug 12, 2024
05:38 PM EDT, 08/12/2024 (MT Newswires) -- B Lynne Parshall, Director, on August 12, 2024, sold 5,000 shares in Cytokinetics ( CYTK ) for $276,000. Following the Form 4 filing with the SEC, Parshall has control over a total of 20,600 shares of the company, with 20,600 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000112760224022026/xslF345X03/form4.xml ...
Cytokinetics Insider Sold Shares Worth $634,455, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $634,455, According to a Recent SEC Filing
Aug 12, 2024
05:37 PM EDT, 08/12/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on August 12, 2024, sold 11,500 shares in Cytokinetics ( CYTK ) for $634,455. Following the Form 4 filing with the SEC, Blum has control over a total of 403,578 shares of the company, with 399,412 shares held directly and 4,166 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000112760224022027/xslF345X03/form4.xml...
American Healthcare REIT Files Mixed Securities Shelf
American Healthcare REIT Files Mixed Securities Shelf
Aug 12, 2024
05:38 PM EDT, 08/12/2024 (MT Newswires) -- American Healthcare REIT ( AHR ) filed an automatic shelf registration statement with the US Securities and Exchange Commission on Monday covering the potential sale of its common and preferred stock and warrants from time to time in one or more offerings. The statement also covers the potential sale of up to 3.5...
Copyright 2023-2026 - www.financetom.com All Rights Reserved